Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Tenaya Therapeutics, Inc.
*MAILING ADDRESS
171 Oyster Point Blvd., Suite 500
*CITY
South San Francisco
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94080
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
035
*IDENTIFICATION
Business consulting and project management in the field of clinical trials, namely, providing information management services; business
consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and management of
clinical trial execution by providing independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management of clinical
trial execution; providing technical consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials, clinical
trial subject recruitment and enrollment for clinical trials, and processing business documents relating to clinical trials, and information management services, namely, clinical data management to
medical, pharmaceutical and technology companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data
for business purposes; statistical analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing
referrals of subjects for enrollment in clinical trials
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research,
namely, conducting clinical trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and
implementation project management of clinical trials
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Aaron D. Hendelman
ATTORNEY DOCKET NUMBER
50971-TM1001
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
WILSON SONSINI GOODRICH & ROSATI
STREET
650 Page Mill Road
CITY
Palo Alto
STATE
California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
94304
PHONE
650-493-9300
FAX
6504936811
EMAIL ADDRESS
trademarks@wsgr.com
OTHER APPOINTED ATTORNEY
all other attorneys of Wilson Sonsini Goodrich & Rosati
CORRESPONDENCE INFORMATION
NAME
Aaron D. Hendelman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
trademarks@wsgr.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
700
*TOTAL FEES PAID
700
SIGNATURE INFORMATION
SIGNATURE
/Jennifer Drimmer Rokovich/
SIGNATORY'S NAME
Jennifer Drimmer Rokovich
SIGNATORY'S POSITION
General Counsel
SIGNATORY'S PHONE NUMBER
000-000-0000
DATE SIGNED
04/03/2023
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97876248
Filing Date:04/06/2023
To the Commissioner for Trademarks:
MARK: RIDGE (Standard Characters, see mark)
The literal element of the mark consists of RIDGE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Tenaya Therapeutics, Inc., a corporation of Delaware, having an address of
171 Oyster Point Blvd., Suite 500
South San Francisco, California 94080
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 035: Business consulting and project management in the field of clinical trials, namely, providing information management services; business consulting and management in the
field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes and management of clinical trial execution by providing
independent review of clinical trials for business purposes; business consulting and management in the field of clinical trials, namely, management of clinical trial execution; providing technical
consulting services in the field of marketing and advertising for clinical trials, verifying clinical trial subject eligibility for clinical trials, clinical trial subject recruitment and enrollment
for clinical trials, and processing business documents relating to clinical trials, and information management services, namely, clinical data management to medical, pharmaceutical and technology
companies in order to assist them with clinical research, clinical trials and applications for drug approval; compilation of statistics and clinical trial data for business purposes; statistical
analysis for business purposes; preparing and placing advertisements for others, namely, to recruit subjects for participation in clinical trials; providing referrals of subjects for enrollment in
clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical
trials for others; Providing information on clinical studies via an interactive website; Consulting services for others in the field of design, planning, and implementation project management of
clinical trials
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Aaron D. Hendelman. Other appointed attorneys are all other attorneys of Wilson Sonsini Goodrich & Rosati. Aaron D. Hendelman of WILSON
SONSINI GOODRICH & ROSATI, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
650 Page Mill Road
Palo Alto, California 94304
United States
650-493-9300(phone)
6504936811(fax)
trademarks@wsgr.com
The docket/reference number is 50971-TM1001.
Aaron D. Hendelman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Aaron D. Hendelman
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@wsgr.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Jennifer Drimmer Rokovich/ Date: 04/03/2023
Signatory's Name: Jennifer Drimmer Rokovich
Signatory's Position: General Counsel
Signatory's Phone Number: 000-000-0000
Signature method: Sent to third party for signature
Payment Sale Number: 97876248
Payment Accounting Date: 04/06/2023
Serial Number: 97876248
Internet Transmission Date: Thu Apr 06 16:01:10 ET 2023
TEAS Stamp: USPTO/BAS-XXX.X.XXX.XXX-2023040616011094
0586-97876248-860815362b4b62aaa73db3dfed
cdf810dc258cdf5c4c44fec2edd0385c4bccd8c9
-DA-01109593-20230308123404853556